国际尿失禁咨询问卷ICIQ-UI SF与ICIQ-LUTSqol的最小临床重要差值
本研究基于一项随机临床试验数据,采用锚定法和分布法估计女性压力性尿失禁非手术治疗中ICIQ-UI SF与ICIQ-LUTSqol的最小临床重要差值(MCID)。12个月随访时106例(88.3%)完成随访并纳入分析,经三角验证后确定ICIQ-UI SF的MCID为4分、ICIQ-LUTSqol的MCID为6分,即分别降低4分和6分被视为具有临床意义。
要点
- ICIQ-UI SF降低4分、ICIQ-LUTSqol降低6分可作为非手术治疗女性压力性尿失禁的临床有意义改善阈值。
- 锚定法估计的MCID范围分别为3.4–4.4分和4.8–6.9分,分布法为1.7分和5.2分。
- 该MCID适用于接受非手术治疗的女性压力性尿失禁人群。
核心结论
- 对于因尿失禁接受非手术治疗的女性,ICIQ-UI SF降低4分、ICIQ-LUTSqol降低6分被视为具有临床意义。
研究设计与样本
- 基于一项评估非手术干预治疗女性压力性尿失禁疗效的随机临床试验数据进行分析。
- 12个月随访时106例(88.3%)参与者完成随访并纳入分析。
主要发现
- ICIQ-UI SF的锚定法MCID范围为3.4–4.4分,分布法MCID为1.7分。
- ICIQ-LUTSqol的锚定法MCID范围为4.8–6.9分,分布法MCID为5.2分。
- 经三角验证,ICIQ-UI SF的MCID为4分,ICIQ-LUTSqol的MCID为6分最为合适。
关键数值与推荐
- ICIQ-UI SF总分范围0–21分,分值越高表示严重程度越高。
- ICIQ-LUTSqol总分范围19–76分,分值越高表示对生活质量影响越大。
- 锚定法采用的锚点为患者整体改善印象、患者满意度、1小时尿垫试验和尿失禁发作频率。
- 分布法采用效应量为0.5个标准差。
临床怎么用
- 在女性压力性尿失禁非手术治疗的效果评估中,ICIQ-UI SF改善达到4分或ICIQ-LUTSqol改善达到6分可视为患者感知的临床有意义改善。
局限性
- MCID基于接受非手术治疗的压力性尿失禁女性样本,外推至其他人群或治疗方式需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the minimum clinically important difference (MCID) of the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) and the International Consultation on Incontinence Questionnaire-Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) using both anchor-based and distribution-based methods for women with stress urinary incontinence undergoing nonsurgical treatment. MATERIALS AND METHODS: Data from a randomized clinical trial evaluating efficacy of a nonsurgical intervention in women with stress urinary incontinence were used for analyses. The overall score of ICIQ-UI SF ranges from 0 to 21, with greater values indicating increased severity. The ICIQ-LUTSqol ranges from 19 to 76, with greater values indicating increased impact on quality of life. Instruments used in the anchor-based method were the Patient Global Impression of Improvement, patient satisfaction, 1-hour pad test and the incontinence episode frequency. The distribution-based method used an effect size of 0.5 standard deviation. Triangulation of findings was used to converge on a single value of MCID. RESULTS: At 12-month post-treatment, 106 (88.3%) participants completed the follow-up and were included in the analysis. Anchor-based MCIDs of the ICIQ-UI SF were between 3.4 and 4.4, while the distribution-based MCID was 1.7. Anchor-based MCIDs of the ICIQ-LUTSqol were between 4.8 and 6.9, while the distribution-based MCID was 5.2. Triangulation of findings showed that MCIDs of 4 for ICIQ-UI SF and 6 for ICIQ-LUTSqol were the most appropriate. CONCLUSION: For women undergoing nonsurgical treatments for incontinence, reductions of 4 and 6 points in ICIQ-UI SF and ICIQ-LUTSqol, respectively are perceived as clinically meaningful.
引用
- Lim R, Liong ML, Lim KK, et al. The Minimum Clinically Important Difference of the International Consultation on Incontinence Questionnaires (ICIQ-UI SF and ICIQ-LUTSqol). Urology. 2019. PMID: 31415780. doi:10.1016/j.urology.2019.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。